Evidence-backed European AI register
Owkin
Reviewed identity, roles, model listings, pricing and evidence for Owkin.
Dataset compiled 2026-08-28 · evidence over inference
Reviewed identity
- Headquarters scope
- EU headquarters
- Headquarters country
- France
- Headquarters city
- Paris
- Legal entity
- SAS (with US entity)
- Ownership
- VC- and corporate-backed private; unicorn since 2021
- Founded
- 2016
- Confidence
- medium
- Last verified
- 2026-08-22
Headquarters evidence
Venue: Owkin HQ, Paris
Owkin's own site labels its Paris site 'Owkin HQ, Paris' (also 'Owkin Paris HQ'), binding HQ wording to the organisation and the city. Medium because the evidence is a venue label rather than a corporate statement, and Owkin also has a substantial New York presence.
Evidence boundaries
Organisation listings identify a reviewed canonical record. Headquarters is independent of incorporation, registered offices, ownership, hosting and runtime. Model listings show an association in the source register; they do not by themselves establish model creation, current API availability, hosting location or infrastructure ownership.
Model listings
- K Navigator
- Type
- text
- Parameters
- unknown
- Context
- unknown
- Languages
- English
- Licence
- proprietary
- Release
- 2025
- K Pro (AI Scientist platform)
- Type
- text
- Parameters
- unknown
- Context
- unknown
- Languages
- English
- Licence
- proprietary
- Release
- 2026
- H0-mini (with Bioptimus)
- Type
- image
- Parameters
- unknown
- Context
- unknown
- Languages
- n/a
- Licence
- unknown
- Release
- 2025
- CytoSyn
- Type
- image
- Parameters
- unknown
- Context
- unknown
- Languages
- n/a
- Licence
- unknown
- Release
- 2026
Profile note
France's biggest AI-for-biology company and the parent of the French pathology-FM lineage (Bioptimus was founded by ex-Owkin scientists; Owkin spun out Waiv with $33M in March 2026). Trains its own multimodal biomedical models and runs MOSAIC, the largest spatial-omics dataset in oncology. Fully gated pricing.
Record sources
- https://www.owkin.com/newsfeed/owkin-launches-k-navigator-a-ground-breaking-agentic-co-pilot-to-speed-up-brea…
- https://www.owkin.com/newsfeed/owkin-becomes-unicorn-with-180m-investment-from-sanofi-and-four-new-collaborat…
- https://www.owkin.com/publications/cytosyn-a-foundation-diffusion-model-for-histopathology-tech-report
- https://tracxn.com/d/companies/owkin/__WnmjWRMn3N8P5-sOf__VolA6J4cK4gv4cxQXRicLJLs
- https://www.owkin.com/